Lotus Pharmaceuticals bought land rights to property in Inner Mongolia on which it will construct a manufacturing facility. Liang Fang Pharmaceutical Company, a China subsidiary of Lotus, paid 108 million RMB ($15.5 million) for the rights, of which 39 million RMB ($5.8 million) was paid to Cha You's Cha Ha Er Industrial Garden District. The first products planned for manufacture at the new factory include saline for intravenous use and blood plasma substitutes. More details...

Stock Symbol: (OTCBB: LTUS)